(Q34371127)

1 August 2017

0 references

Circulating 25-hydroxyvitamin D serum concentration and total cancer incidence and mortality: a systematic review and meta-analysis (English)

1 reference

1 August 2017

0 references

1 reference

1 reference

4

1 reference

1 August 2017

6

1 reference

1 August 2017

José M Ordóñez-Mena

2

0 references

Lu Yin

object named as

Lu Yin

series ordinal

1

0 references

Volker Arndt

series ordinal

5

object named as

Volker Arndt

1 reference

1 August 2017

Tianhui Chen

3

1 reference

1 August 2017

language of work or name

English

0 references

publication date

10 September 2013

1 reference

1 August 2017

1 reference

1 August 2017

volume

57

1 reference

1 August 2017

issue

6

1 reference

1 August 2017

page(s)

753-764

1 reference

Low plasma 25-hydroxyvitamin D and risk of tobacco-related cancer

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Commentary: seeing the light

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and/or calcium (RECORD trial).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993-2002.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

The effect of calcium plus vitamin D on risk for invasive cancer: results of the Women's Health Initiative (WHI) calcium plus vitamin D randomized clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Associations of diet, supplement use, and ultraviolet B radiation exposure with vitamin D status in Swedish women during winter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Higher blood 25(OH)D level may reduce the breast cancer risk: evidence from a Chinese population based case-control study and meta-analysis of the observational studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Serum 25-hydroxyvitamin D concentration and risk for major clinical disease events in a community-based population of older adults: a cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Meta-analysis in clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Prospective association of vitamin D concentrations with mortality in postmenopausal women: results from the Women's Health Initiative (WHI).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

The relationship between ultraviolet radiation exposure and vitamin D status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Do sunlight and vitamin D reduce the likelihood of colon cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Calcium plus Vitamin D and the Risk of Colorectal Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Methods for Trend Estimation from Summarized Dose-Response Data, with Applications to Meta-Analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: the Tromsø study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. The Tromsø Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Calcium, vitamin D, sunshine exposure, dairy products and colon cancer risk (United States).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Uncertain verdict as vitamin D goes on trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Vitamin D supplementation and cancer: review of randomized controlled trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Circulating levels of vitamin D and colon and rectal cancer: the Physicians' Health Study and a meta-analysis of prospective studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Prospective study of serum 25-hydroxyvitamin D concentration and mortality in a Chinese population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Plasma vitamin D and mortality in older men: a community-based prospective cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Meta-analysis: formulating, evaluating, combining, and reporting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Serum 25-Hydroxyvitamin D and Cancer Risk in Older Adults: Results from a Large German Prospective Cohort Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Low serum levels of 25-hydroxyvitamin D predict fatal cancer in patients referred to coronary angiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Disease prevention: vitamin D trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Vitamin D and cancer mortality: systematic review of prospective epidemiological studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

A vitamin D3 analog induces a G1-phase arrest in CaCo-2 cells by inhibiting cdk2 and cdk6: roles of cyclin E, p21Waf1, and p27Kip1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Standardization of misleading immunoassay based 25-hydroxyvitamin D levels with liquid chromatography tandem-mass spectrometry in a large cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

A prospective study of serum 25-hydroxyvitamin d levels and mortality among African Americans and non-African Americans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Vitamin D status and cause-specific mortality: a general population study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Advanced methods in meta-analysis: multivariate approach and meta-regression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Vitamin D and prevention of colorectal adenoma: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Meta-analysis of longitudinal studies: Serum vitamin D and prostate cancer risk.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Meta-analysis: Circulating vitamin D and ovarian cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Meta-analysis: Serum vitamin D and colorectal adenoma risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

Blood biomarkers of vitamin D status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.08.026

10.1016/J.YPMED.2013.08.026

7 January 2021

Identifiers

DOI

1 reference

1 August 2017

1 reference